Nuzenio

Hold Rating Reiterated

Hold Rating Reiterated news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Bernie McTernan Reiterates Hold on PENN as Strong Casino Results Offset by Balanced Risk-Reward Outlook - TipRanksTipRanks · Fri, 07 Aug 2026 22:30:55 GMTDeutsche Bank Aktiengesellschaft Reiterates "Hold" Rating for Derwent London (LON:DLN) - MarketBeatMarketBeat · Fri, 07 Aug 2026 18:40:54 GMTAnalyst Reiterates Hold on DraftKings as Outlook and $27 Price Target Remain Unchanged Amid Profitability Concerns - TipRanksTipRanks · Fri, 07 Aug 2026 12:19:25 GMTGoldman Sachs Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 12:02:00 GMTHold Rating Reiterated on Alector as Early-Stage Alzheimer’s Pipeline Keeps Risk–Reward Balanced - TipRanksTipRanks · Fri, 07 Aug 2026 11:01:41 GMTHost Hotels & Resorts: Hold Rating Reiterated as Strong RevPAR and Raised Guidance Offset by Rich Valuation; $22 Price Target Maintained - TipRanksTipRanks · Thu, 06 Aug 2026 16:45:44 GMTNeedham reiterates Hold on Zimmer Biomet stock after Q2 beat - Investing.comInvesting.com · Wed, 05 Aug 2026 20:05:14 GMTJefferies Financial Group Reiterates "Hold" Rating for BP (LON:BP) - MarketBeatMarketBeat · Wed, 05 Aug 2026 16:29:36 GMT

Timeline

Fri, 07 Aug 2026 22:30:55 GMTBernie McTernan Reiterates Hold on PENN as Strong Casino Results Offset by Balanced Risk-Reward Outlook - TipRanks
Fri, 07 Aug 2026 18:40:54 GMTDeutsche Bank Aktiengesellschaft Reiterates "Hold" Rating for Derwent London (LON:DLN) - MarketBeat
Fri, 07 Aug 2026 12:19:25 GMTAnalyst Reiterates Hold on DraftKings as Outlook and $27 Price Target Remain Unchanged Amid Profitability Concerns - TipRanks
Fri, 07 Aug 2026 12:02:00 GMTGoldman Sachs Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and Mail
Fri, 07 Aug 2026 11:01:41 GMTHold Rating Reiterated on Alector as Early-Stage Alzheimer’s Pipeline Keeps Risk–Reward Balanced - TipRanks
Thu, 06 Aug 2026 16:45:44 GMTHost Hotels & Resorts: Hold Rating Reiterated as Strong RevPAR and Raised Guidance Offset by Rich Valuation; $22 Price Target Maintained - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Hold Rating Reiterated.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.